Alan L Hudson
Biographic Data
| ID | 7372430 |
|---|---|
| NAME | Alan L Hudson |
| GIVEN NAMES | Alan L |
| FAMILY NAME | Hudson |
| SIGNATURE | HUDSON A L |
| AFFILIATIONS | University of Alberta |
| ORCID | 0000-0003-1105-7646 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 0 |
Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects
Decreased cognitive ability is a significant problem in schizophrenia, and it has been proposed that augmentation of antipsychotics with 5HT(1A) receptor agonists may improve cognitive performance. Clinical studies have been mixed but there have been no studies specifically examining the effects of combining the atypical antipsychotic quetiapine with the 5HT(1A) receptor partial agonist, buspirone on monoamine release. This is of interest given p…
No prominent works on this page.
Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects
Decreased cognitive ability is a significant problem in schizophrenia, and it has been proposed that augmentation of antipsychotics with 5HT(1A) receptor agonists may improve cognitive performance. Clinical studies have been mixed but there have been no studies specifically examining the effects of combining the atypical antipsychotic quetiapine with the 5HT(1A) receptor partial agonist, buspirone on monoamine release. This is of interest given p…
5-HT receptor (1 work) · Agonist (1 work) · Antipsychotic (1 work) · Atypical antipsychotic (1 work) · Buspirone (1 work) · Dopamine (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Monoamine neurotransmitter (1 work) · Neurotransmitter Receptor Influence on Behavior (1 work)